CXCL8 and prostate carcinoma: cIAP1 is an anti-apoptotic protein that is upregulated in prostate cancer cells following CXCL8-mediated TAM infiltration, and cIAP1 inhibition has been shown to be effective in PTEN-depleted prostate cancer cells in vitro [84].